Involvement of protein-DNA interaction in adeno-associated virus Rep78-mediated inhibition of HIV-1

Journal of Human Virology

Volumn 1, Issue 7, 1998, Pages 441-450

  Kokorina, Natalia A ^a   Santin, Alessandro D ^a   Li, Chunting ^a   Hermonat, Paul L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Adeno associated virus; HIV 1; Rep78; Transcription

Indexed keywords

DNA BINDING PROTEIN; REP PROTEINS, ADENO ASSOCIATED VIRUS 2; REP PROTEINS, ADENO-ASSOCIATED VIRUS 2; TRANSCRIPTION FACTOR; VIRUS DNA; VIRUS PROTEIN;

ADENO ASSOCIATED VIRUS; ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; METABOLISM; MUTATION; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; TATA BOX; VIRUS INTERFERENCE; VIRUS REPLICATION;

DEPENDOVIRUS; DNA, VIRAL; DNA-BINDING PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MUTATION; TATA BOX; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VIRAL INTERFERENCE; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0032199766     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Wollscheid V, Frey M, Zentgraf H, Sczakiel G. Purification and characterization of an active form of the p78(REP) protein of adeno-associated virus type 2 expressed in Escherichia coli. Protein Expr Purif 1997;11:241-249.
2. Horer M, Weger S, Butz K, Hoppe-Seyler F, Geisen C, Kleinschmidt JA. Mutational analysis of adeno-associated virus Rep78 protein mediated inhibition of heterologous and homologous promoters. J Virol 1995;69:5485-5496.
3. Oelze I, Rittner K, Sczakiel G. Adeno-associated virus type 2 rep gene-mediated inhibition of basal gene expression of human immunodeficiency virus type 1 involves its negative regulatory functions. J Virol 1994;68: 1229-1233.
4. Rittner K, Heilbronn R, Kleinschmidt JA, Sczakiel G. Adeno-associated virus type 2-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) replication: involvement of p78rep/p68rep and the HIV long terminal repeat. J Gen Virol 1992;73:2977-2981.
5. Mendelson E, Grossman F, Mileguir F, Rechavi G, Carter BJ. Replication of adeno-associated virus type 2 in human lymphocytic cells and interaction with HIV-1. Virology 1992;187:453-463.
6. Rittner K, Heilbronn R, Kleinschmidt JA, Oelze I, Sczakeil G. Replication of the human immunodeficiency virus type 1 is inhibited by the adeno-associated virus rep gene. Biochem Soc Trans 1991;19:438S.
7. Antoni BA, Rabson AB, Miller IL, Trempe JP, Chejanovsky N, Carter BJ. Adeno-associated virus rep protein inhibits human immunodeficiency virus type 1 production in human cells. J Virol 1991;65:396-404.
8. Hermonat PL, Labow MA, Wright R, Berns KI, Muzyczka N. Genetics of adeno-associated virus: isolation and preliminary characterization of mutants in adeno-associated virus. J Virol 1984;51:329-339.
9. Tratschin JD, Miller IL, Carter BJ. Genetics of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function. J Virol 1984;51:611-619.
10. Im DS, Muzyczka N. The origin binding protein Rep68 is an ATP-dependent site-specific endo-nuclease with DNA helicase activity. Cell 1990;61:447-457.
11. Im DS, Muzyczka N. Factors that bind to the adeno-associated virus terminal repeats. J Virol 1989;63:3095-3104.
12. Im DS, Muzyczka N. Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization. J Virol 1992;66:1119-1128.
13. Owens RA, Weitzman MD, Kyostio SRM, Carter BJ. Identification of a DNA-binding domain in the amino terminus of adeno-associated virus Rep proteins. J Virol 1993; 67:997-1005.
14. Chiorini JA, Weitzman MD, Owens RA, Urcelay E, Safer B, Kotin RM. Biologically active Rep proteins of adeno-associated virus type 2 produced as fusion proteins in Escherichia coli. J Virol 1994;74:794-804.
15. Batchu RB, Kotin RM, Hermonat PL. The regulatory rep protein of adeno-associated virus binds to sequences within the c-H-ras promoter. Cancer Lett 1994;86:23-31.
16. Batchu RB, Miles DA, Rechtin TM, Drake RR, Hermonat PL. Cloning, expression and purification of full length Rep78 of adeno-associated virus as a fusion protein with maltose binding protein in Escherichia coli. Biochem Biophys Res Comm 1995;208:714-720.
17. Batchu RB, Hermonat PL. Dissociation of conventional DNA binding and endonuclease activities by an adeno-associated virus Rep78 mutant. Biochem Biophys Res Comm 1995;210:717-725.
18. Labow MA, Hermonat PL, Berns KI. Positive and negative autoregulation of the adeno-associated virus type 2 genome. J Virol 1986;60:251-258.
19. Tratschin JD, Tal J, Carter BJ. Negative and positive regulation in trans of gene expression from adeno-associated virus vectors in mammalian cells by a viral rep gene product. Mol Cell Biol 1986;6:2884-2894.
20. Ashktorab H, Srivastava A. Identification of nuclear proteins that specifically interact with adeno-associated virus type 2 inverted terminal repeat hairpin DNA. J Virol 1989; 63:3034-3039.
21. Kotin RM, Siniscalco M, Samulski RJ, et al. Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 1990;87:2211-2215.
22. Samulski RJ, Zhu X, Xiao X, et al. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J 1992;10:3941-3950.
23. Weitzman MD, Kyostio SR, Kotin RM, Owens RA. Adeno-associated virus (AAV) Rep protein mediate complex formation between AAV DNA and its integration site in human DNA. Proc Natl Acad Sci U S A 1994;94:5806-5812.
24. Chiorini JA, Yang L, Safer B, Kotin RM. Determination of adeno-associated virus Rep68 and Rep78 binding sites by random sequence oligonucleotide selection. J Virol 1995; 69:7334-7338.
25. Batchu RB, Hermönat PL. The trans-inhibitory Rep78 protein of adeno-associated virus binds to TAR region DNA of the human immunodeficiency virus type 1 long terminal repeat. FEBS Lett 1995;367:267-271.
26. Gendelman HE, Phelps W, Feigenbaum L, et al. Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc Natl Acad Sci U S A 1986;83:9759-9763.
27. Hermonat PL, Plott RT, Santin AD, Parham GP, Flick JT. Adeno-associated virus Rep78 inhibits oncogenic transformation of primary human keratinocytes by a human papillomavirus type 16-ras chimeric. Gynecol Oncol 1997;66:487-494.
28. Hermonat PL, Santin AD, Batchu RB. The adeno-associated virus Rep78 major regulatory/transformation suppressor protein binds cellular Sp1 in vitro and evidence of a biological effect. Cancer Res 1996;56:5299-5304.
29. Pereira DJ, Muzyczka N. The cellular transcription factor Sp1 and an unknown cellular protein are required to mediate Rep protein activation of the adeno-associated virus p19 promoter. J Virol 1997;71:1747-1756.
30. Hermonat PL, Santin AD, Batchu RB, Zhan D-J. The adeno-associated virus Rep78 major regulatory protein binds the cellular TATA-binding protein, TBP, in vitro and in vivo. Virology 1998;245:120-127.
31. Katz E, Carter BJ. Effect of adeno-associated virus on transformation of NIH 3T3 cells by ras gene gene and on tumorigenicity of an NIH 3T3 transformed cell line. Cancer Res 1986;46:3023-3026.
32. Hermonat PL. Inhibition of H-ras expression by the adeno-associated virus Rep78 transformation suppressor gene product. Cancer Res 1991;51:3373-3377.
33. Khleif SN, Myers T, Carter BJ, Trempe JP. Inhibition of cellular transformation by adeno-associated virus rep gene. Virology 1991;181:738-741.
34. Hermonat PL. Adeno-associated virus inhibits human papillomavirus type 16: a viral interaction implicated in cervical cancer. Cancer Res 1994;54:2278-2281.
35. Hermonat PL. Down-regulation of the human c-fos and c-myc proto-oncogene promoters by adeno-associated virus Rep78. Cancer Lett 1994;81:129-136.
36. Wonderling RS, Kyostio SR, Walker, SL, Owens RA. The Rep68 protein of adeno-associated virus type 2 increases RNA levels from the human cytomegalovirus immediate early promoter. Virology 1997;236:167-176.
37. Wonderling RS, Owens RA. The Rep68 protein of adeno-associated virus type 2 stimulates expression of the platelet-derived growth factor B c-sis proto-oncogene. J Virol 1996;70:4783-4786.
38. Parada CA, Yoon J-B, Roeder RG. A novel LBP-1-mediated restriction of HIV-1 transcription at the level of elongation in vitro. J Biol Chem 1995;270:2274-2283.
39. McCarty DM, Pereira DJ, Zolotukin I, Zhou X, Ryan JH, Muzyczka N. Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein. J Virol 1994;68:4988-4997.
40. Hermonat PL, Batchu RB. The adeno-associated virus Rep78 major regulatory protein forms multimeric complexes and the domain for this activity is within the carboxy-half of the molecule. FEBS Lett 1997;401:180-184.
41. Bishop BM, Santin AD, Quirk JG, Hermonat PL. Role of the terminal repeat GAGC-trimer, the major Rep78 binding site, in adeno-associated virus DNA replication. FEBS Lett 1996;397:97-100.